Carol Costello: There's going to be a fair amount of confusion here. The inno compromise patients are particularly a concernd. They don't form antabodies as well, because part of your immune system responds to the shops. So that group really has several reasons why a booster shop made sense.
Dr. Ian Lustbader, Clinical Professor of Medicine at NYU Langone, discusses the FDA approval of a third Covid vaccine shot for people with weak immune systems. Bloomberg Businessweek Editor Joel Weber and Bloomberg News U.S. Health Care Reporter Cynthia Koons discuss Cynthia's Businessweek Magazine story Don’t Lose Sight of Fact That Covid Vaccines Are Working. Bloomberg Opinion Healthcare Columnist Max Nisen discusses the "Tesla-fication"of Moderna. And we Drive to the Close with Rebecca Corbin, CEO of Corbin Advisors.
Host: Carol Massar. Producer: Paul Brennan.
See omnystudio.com/listener for privacy information.